Immunogenicity 14490
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SPATA20
Transcript ID
NM_022827
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (802 aa)
MLGAR
1
AWLGR
6
VLLLP
11
RAGAG
16
LAASR
21
RCPGV
26
WPRTW
31
PHRSP
36
SRGSS
41
SRDKD
46
RSATV
51
SSSVP
56
MPAGG
61
KGSHP
66
SSTPQ
71
RVPNR
76
LIHEK
81
SPYLL
86
QHAYN
91
PVDWY
96
PWGQE
101
AFDKA
106
RKENK
111
PIFLS
116
VGYST
121
CHWCH
126
MMEEE
131
SFQNE
136
EIGRL
141
LSEDF
146
VSVKV
151
DREER
156
PDVDK
161
VYMTF
166
VQATS
171
SGGGW
176
PMNVW
181
LTPNL
186
QPFVG
191
GTYFP
196
PEDGL
201
TRVGF
206
RTVLL
211
RIREQ
216
WKQNK
221
NTLLE
226
NSQRV
231
TTALL
236
ARSEI
241
SVGDR
246
QLPPS
251
AATVN
256
NRCFQ
261
QLDEG
266
YDEEY
271
GGFAE
276
APKFP
281
TPVIL
286
SFLFS
291
YWLSH
296
RLTQD
301
GSRAQ
306
QMALH
311
TLKMM
316
ANGGI
321
RDHVG
326
QGFHR
331
YSTDR
336
QWHVP
341
HFEKM
346
LYDQA
351
QLAVA
356
YSQAF
361
QLSGD
366
EFYSD
371
VAKGI
376
LQYVA
381
RSLSH
386
RSGGF
391
YSAED
396
ADSPP
401
ERGQR
406
PKEGA
411
YYVWT
416
VKEVQ
421
QLLPE
426
PVLGA
431
TEPLT
436
SGQLL
441
MKHYG
446
LTEAG
451
NISPS
456
QDPKG
461
ELQGQ
466
NVLTV
471
RYSLE
476
LTAAR
481
FGLDV
486
EAVRT
491
LLNSG
496
LEKLF
501
QARKH
506
RPKPH
511
LDSKM
516
LAAWN
521
GLMVS
526
GYAVT
531
GAVLG
536
QDRLI
541
NYATN
546
GAKFL
551
KRHMF
556
DVASG
561
RLMRT
566
CYTGP
571
GGTVE
576
HSNPP
581
CWGFL
586
EDYAF
591
VVRGL
596
LDLYE
601
ASQES
606
AWLEW
611
ALRLQ
616
DTQDK
621
LFWDS
626
QGGGY
631
FCSEA
636
ELGAG
641
LPLRL
646
KDDQD
651
GAEPS
656
ANSVS
661
AHNLL
666
RLHGF
671
TGHKD
676
WMDKC
681
VCLLT
686
AFSER
691
MRRVP
696
VALPE
701
MVRAL
706
SAQQQ
711
TLKQI
716
VICGD
721
RQAKD
726
TKALV
731
QCVHS
736
VYIPN
741
KVLIL
746
ADGDP
751
SSFLS
756
RQLPF
761
LSTLR
766
RLEDQ
771
ATAYV
776
CENQA
781
CSVPI
786
TDPCE
791
LRKLL
796
HP
801
Mutation Information
DNA mutation:
None
Peptide Range:
273 ~ 297
Mut AA position:
285 (13 in Wild Type peptide)
Alignment
Wild Type:
"EEYGGFAEAPKFPTPVILSFLFSYW
||||||||||||.||||||||||||
Mutant:
EEYGGFAEAPKFSTPVILSFLFSYW"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SPATA20
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay